More Business Wire
View Older Stories View Newer Stories-
Quantum PKI Appoints Dr. Judy Gounden as Chief Executive Officer to Drive Global Growth and Digital Trust Innovation
-
Presto Adds $10M to Accelerate AI Leadership for Enterprise QSR Brands
-
Keystone, a Global Technology and Ecosystem Advisory Platform, Announces Strategic Investment and Partnership with Audax Private Equity
-
Murphy Oil Corporation Announces Offering of $500 Million of Senior Notes Due 2034
-
Cizzle Brands Adds Vertical Integration With $83.75M Acquisition of Flow Water Inc.; Secures Minimum Volume Commitments worth $184M in Manufacturing Contracts
-
A.R.I. Acquires Controlling Majority Interest in Lights Out Sports
-
Cyera Raises $400M to Meet Rapidly Growing Demand for AI Security Among Enterprises
-
Liberty Latin America Expands Exclusive International Voice Managed Services Partnership with BTS to 22 Additional Caribbean Markets
-
Lincoln Electric Schedules 2026 Annual Meeting of Shareholders
-
Soluna and Siemens Collaborate to Solve GPU Power Swings in Behind-the-Meter AI
-
USA TODAY Co. to Present at the 28th Annual Needham Growth Conference
-
Kforce Inc. Announces Participation in Barclays 43rd Annual Industrial Select Conference
-
Det-Tronics Acquires Optronics
-
Ukrainian Journalists Learn How to Report During a Drone Attack, Through a Program Supported by The Globe and Mail Foundation
-
AccurKardia Secures FDA 510(k) Clearance of and Launches AccurECG 2.0
-
TD SYNNEX Reports Record Fiscal 2025 Fourth Quarter Results
-
Neogen Announces Second-Quarter 2026 Results
-
Coincheck Group Signs Agreement to Acquire 3iQ, a Global Pioneer in Digital Asset Investment Solutions
-
VectorY Therapeutics Receives FDA Fast Track Designation for VTx-002, a First-in-Class Vectorized Antibody Targeting Underlying Disease Biology in ALS
-
Osel Enters Agreement with SWOG Cancer Research Network for First-Ever Pivotal Trial of a Microbiome-Based Therapy in Oncology
-
Bidgely Redefines Energy AI in 2025: From Machine Learning to Agentic AI
-
Xeris Expects to Deliver Record Fourth Quarter and Full-Year 2025 Total Revenue
-
Protege Raises $30 Million Led by a16z to Unlock Access to Data for AI Development
-
Echo Water Unveils the Echo One: An Ultra-Pure Hydrogen Water System
-
TransactionTree Appoints Kevin Saum as Chief Executive Officer to Lead Next Phase of Growth
-
Parabilis Medicines Announces Oversubscribed $305 Million Financing to Support Ongoing FOG-001 (zolucatetide) Clinical Development Across a Broad Range of Tumors and Advance Pioneering Pipeline and He
-
Tubulis Appoints Charles Fuchs, MD as Chief Medical Officer to Lead Clinical Strategy and Pipeline Development
-
Enhanced Digital Group Announces Series A Financing
-
Amylyx Pharmaceuticals Announces Nomination of AMX0318 as a Novel, Long-Acting GLP-1 Receptor Antagonist Development Candidate, Identified in Collaboration with Gubra A/S
-
Canopy Growth Announces Strategic Recapitalization Transactions Significantly Strengthening Balance Sheet to Support Growth Strategy
-
Bruker Consolidates Ownership of TOFWERK in Expansion of Mass Spectrometry Portfolio into New Applied Markets
-
Candid Therapeutics Plans to Initiate Multiple Phase 2 Studies Following Promising Clinical Data of T-cell Engagers in Autoimmune Diseases
-
PlusAI on Track to Launch Factory-Built Commercial Autonomous Trucks Next Year
-
Vizgen Announces $48 Million Financing
-
Enanta Pharmaceuticals Provides Update on its Research and Development Programs and 2026 Outlook
-
NIQ and Kodiak Announce Retail Measurement Agreement to Drive Breakfast Category Growth
-
Tanger Announces Pricing of Upsized Exchangeable Senior Notes Offering
-
K1x and Juno Announce Strategic Partnership to Provide Industry-Leading Tax Automation
-
U.S. Army Selects Striveworks for AI Test and Evaluation
-
Virometix AG Announces Positive Data from Phase 1 Trial of V-212, a Fully Synthetic, Serotype-Independent Vaccine Development Candidate for the Prevention of Pneumococcal Disease
-
SpliceBio Initiates Dose-Expansion Portion of Phase 1/2 ASTRA Clinical Trial for SB-007, a Dual-AAV Gene Therapy for Stargardt Disease
-
Concord Appoints Chris Baker as Executive Chairman
-
Rick R. Suarez appointed US President and Head of US BioPharmaceuticals Business Unit
-
First Foundation Inc. Announces Fourth Quarter 2025 Earnings Release Details
-
The Buckle, Inc. Reports December 2025 Net Sales
-
Helen of Troy Limited Reports Third Quarter Fiscal 2026 Results
-
RPM Reports Fiscal 2026 Second-Quarter Results
-
Lindsay Corporation Reports Fiscal 2026 First Quarter Results
-
eDreams ODIGEO Secures Rulings, Ryanair Fined for Breach of Court Order and Forced to Cease Unlawful Practices
-
Abbelight Announces Successful Series B Investment led by AVANT BIO to Accelerate Imaging Innovation and Scale Adoption Across a Broader Customer Base
